Previous Close | 81.96 |
Open | 81.47 |
Bid | 82.09 x 1100 |
Ask | 82.13 x 800 |
Day's Range | 81.24 - 82.34 |
52 Week Range | 46.78 - 84.03 |
Volume | |
Avg. Volume | 7,890,128 |
Market Cap | 89.899B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | 155.24 |
EPS (TTM) | 0.53 |
Earnings Date | Apr 24, 2023 - Apr 28, 2023 |
Forward Dividend & Yield | 0.32 (0.39%) |
Ex-Dividend Date | Dec 14, 2022 |
1y Target Est | 86.94 |
Subscribe to Yahoo Finance Plus to view Fair Value for GE
Nearly 10% of CEOs from companies that make up the S&P 500 share a Cincinnati connection. The Standard and Poor's 500 stock market index tracks the performance of 500 large companies, and 9.1% of the CEOs of those companies trace their roots to Procter & Gamble (NYSE: PG), according to a new report – "The Role of the CEO 2023" – from global people intelligence firm Altrata. P&G was second among companies whose alumni held the top spot at S&P 500 firms, just behind General Electric, whose former employees make up 10.2% of CEOs of companies on the index.
The recent spinoff of General Electric's (NYSE: GE) healthcare unit, known as GE HealthCare Technologies (NASDAQ: GEHC), has been a hit with investors. Underscoring this point, GE Healthcare's shares have jumped by a healthy 16.6% since their debut on the Nasdaq stock exchange a little over a month ago. Here is the bull-vs.-bear take on GE Healthcare's near-term prospects as a growth vehicle.
The newly listed healthcare company gave its first set of earnings as a stand-alone company, and while there were some negatives, its future looks bright.